Drug: infliximab Quarter: 2016Q3
Total Records: 643 Number of Pages: 33
DRUGNAME | PT | EventCount |
---|---|---|
INFLIXIMAB HOSPIRA | Tongue disorder | 1 |
INFLIXIMAB HOSPIRA | Urinary tract infection bacterial | 1 |
INFLIXIMAB RECOMBINANT | Alanine aminotransferase increased | 1 |
INFLIXIMAB RECOMBINANT | Antinuclear antibody positive | 1 |
INFLIXIMAB RECOMBINANT | Complement factor decreased | 1 |
INFLIXIMAB RECOMBINANT | Double stranded DNA antibody positive | 1 |
INFLIXIMAB RECOMBINANT | Drug effect incomplete | 1 |
INFLIXIMAB RECOMBINANT | Inappropriate schedule of drug administration | 1 |
INFLIXIMAB RECOMBINANT | Mobility decreased | 1 |
INFLIXIMAB RECOMBINANT | Rash | 1 |
INFLIXIMAB RECOMBINANT | Therapeutic response decreased | 1 |
INFLIXIMAB, 100 MG VIAL JANSSEN | Immunosuppression | 1 |
INFLIXIMAB, 100 MG VIAL JANSSEN | Meningitis listeria | 1 |
INFLIXIMAB, RECOMBINANT | Abdominal infection | 1 |
INFLIXIMAB, RECOMBINANT | Abortion induced | 1 |
INFLIXIMAB, RECOMBINANT | Abortion spontaneous | 1 |
INFLIXIMAB, RECOMBINANT | Acute myocardial infarction | 1 |
INFLIXIMAB, RECOMBINANT | Acute respiratory distress syndrome | 1 |
INFLIXIMAB, RECOMBINANT | Alopecia | 1 |
INFLIXIMAB, RECOMBINANT | Anal fistula | 1 |
Total Records: 643 Number of Pages: 33